NCT05323994View on ClinicalTrials.gov

Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR)

CompletedOBSERVATIONAL

Enrollment

104

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

February 20, 2023

Study Completion Date

March 15, 2023

Conditions

DepressionCOVID-19

Trial Locations (1)

Unknown

"Federal State Autonomous Educational Institution of Higher Education Peoples' Friendship University of Russia", Moscow

All Listed Sponsors

lead

Servier Russia

INDUSTRY

NCT05323994 - Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR) | Biotech Hunter | Biotech Hunter